Today's News
Children’s Sunscreens Boost EWG Recommendation Rate In 2012 / The Environmental Working Group says many children’s sunscreens have “safer, more effective ingredients than those in other products.” But the Personal Care Products Council questions EWG’s research, saying the group’s report “could confuse consumers and discourage them from using sunscreen.” / “The Tan Sheet”
Current Issue:
May 14, 2012
OTCs
Perrigo Feels Ill Effects Of Mild Cold Season, Excess OTC Capacity / The private labeler lowered its full-year revenue guidance, noting weak cough/cold/flu OTC sales. Perrigo built up excess capacity to take advantage of recalled Johnson & Johnson OTCs, and now is shifting some capacity in response to a Novartis plant shutdown. / “The Tan Sheet” May 14, 2012
J&J’s Path Forward – An Interview With Alex Gorsky / In a conversation shortly before taking the helm at Johnson & Johnson, CEO Gorsky discusses deal strategies, emerging markets, his experience overseeing both the device and pharma businesses and the value of J&J’s consumer health product portfolio. / “The Tan Sheet” May 14, 2012
International
Regional Firms Must Compete With Multinationals At Home And Away / Regional firms have to face multinationals coming into small and emerging markets, says an Alkaloid AD Skopje exec, but they need to venture into new markets themselves. While multinationals have the benefit of large budgets and proven strategies, smaller companies can more effectively identify and predict key local behavior. / “The Tan Sheet” May 14, 2012
Korea’s National Assembly Passes Long-Awaited OTC Drug Bill / Confronted with mounting public anger, the National Assembly approves the OTC bill as both ruling and opposition parties gear up for the presidential election. / “The Tan Sheet” May 14, 2012
Dietary Supplements
Alacer Sale Underscores Value-Add Of Best Practices / Best practices help establish a firm’s appeal as an acquisition target, illustrated by the case of Pfizer’s acquisition of Emergen-C maker Alacer.` / “The Tan Sheet” May 14, 2012
Supplement AER Under-Reporting Marks Tip Of Compliance Iceberg – FDA / FDA’s dietary supplement program chief raised eyebrows at a botanical products conference citing low estimates on rates of compliance with the good manufacturing practices final rule and the new dietary ingredient notification requirements, as well as adverse event reporting. / “The Tan Sheet” May 14, 2012
News in Brief
Sales & Earnings In Brief / Vitamin Shoppe shrugs off DMAA warnings; Teva grows OTCs, transitions CEO; Reckitt’s Mucinex still ahead of private label; DSM nutrition still up from Martek acquisition; more Sales & Earnings In Brief. / “The Tan Sheet” May 14, 2012
New Products In Brief / Abbott’s Revigor fuels EAS sports nutrition line; Tahitian Noni rebrands as Morinda Bioactives and gets “Fit”; Nordic Naturals tries veggie omega-6 with Nordic GLA oil; Solgar’s minnows sweeten fish oil proposition; Mannatech puts “Real Food” in NutriVerus powder; more New Products In Brief. / “The Tan Sheet” May 14, 2012
In Brief / FDA softens disclaimer for green tea QHC; Formulife/Purus covers spectrum of violations; NAD refers Schick case to FTC; Genomma drops Prestige Brands board bid. / “The Tan Sheet” May 14, 2012
FDA
FDA IT Systems In Senate Appropriators’ Crosshairs / The Senate Appropriations Committee approves a $3.9 billion spending plan for the agency in fiscal 2013, providing a $12.5 million boost in direct funding over President Obama’s proposed budget, with the extra funds slated for the food and animal drug programs. / “The Tan Sheet” May 14, 2012
FDA Toots Its Own Horn On Safety Of Marketed Drugs, Imports / FDA’s Global Engagement report describes the agency’s actions to protect the international supply chain. Meanwhile, the Advances in FDA’s Safety Program for Marketed Drugs report notes label changes and safety studies mandated under its post-market drug safety program. / “The Tan Sheet” May 14, 2012
FDA Needs More Aggressive Globalization Strategy – Sen. Brown / The Ohio Democrat says FDA should be more creative in dealing with globalization problems than asking for funds to put more inspectors in China. Commissioner Hamburg says the agency is aggressive but lacks tools and resources to fully address globalization issues. / “The Tan Sheet” May 14, 2012
Recalls
FDA Recalls For May 9, 2012 / Recalls reported by FDA for OTC drugs, nutritionals and personal care products. / “The Tan Sheet” May 14, 2012
Trademarks
Weekly Trademark Review May 8, 2012 / OTC drug, personal care product and nutriotional supplement trademark filings compiled by “The Tan Sheet” from Official Gazette of the U.S. Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps; and Class 5 – Pharmaceuticals. / “The Tan Sheet” May 14, 2012